Farringdon Capital, Ltd. Penumbra Inc Transaction History
Farringdon Capital, Ltd.
- $242 Billion
- Q4 2024
A detailed history of Farringdon Capital, Ltd. transactions in Penumbra Inc stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 2,661 shares of PEN stock, worth $714,930. This represents 0.26% of its overall portfolio holdings.
Number of Shares
2,661Holding current value
$714,930% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding PEN
# of Institutions
410Shares Held
29.1MCall Options Held
247KPut Options Held
152K-
Black Rock Inc. New York, NY4.26MShares$1.14 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$981 Million0.02% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.5MShares$402 Million2.36% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.27MShares$340 Million0.03% of portfolio
-
State Street Corp Boston, MA1.2MShares$323 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $10.2B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...